Skip to main content
Clinical Trials/NCT03782038
NCT03782038
Unknown
Not Applicable

A Prospective, Multi-center, Pilot Study to Evaluate the Safety and Efficacy of the Cytrellis Micro-Coring Device for the Treatment of Scars

Cytrellis Biosystems, Inc.1 site in 1 country30 target enrollmentSeptember 13, 2018
ConditionsScars

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Scars
Sponsor
Cytrellis Biosystems, Inc.
Enrollment
30
Locations
1
Primary Endpoint
Assess level of aesthetic improvement using ASAS scale 6 months post last treatment
Last Updated
7 years ago

Overview

Brief Summary

A study to evaluate the safety and effectiveness of a micro coring device for the treatment of scars.

Detailed Description

The study subject population will consist to up to 30 subjects who meet the inclusion/exclusion criteria. All subjects will be monitored for a period of 6 months post last treatment. An study results will be assessed on the following: * POSAS - Patient Observer Scar Assessment * ASAS - Acne Scar Severity Scale * Subject Satisfaction Scale

Registry
clinicaltrials.gov
Start Date
September 13, 2018
End Date
November 21, 2019
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older
  • Fitzpatrick scale I-VI.
  • Any type of scar except for keloid scars
  • Able to provide written informed consent, understand and willing to comply with study related procedures and follow-ups.

Exclusion Criteria

  • Previous treatment of the scar tissue within last 6 months.
  • Silicone, fat, collagen or synthetic material in the treatment area.
  • History of keloid formation.
  • Active smokers (smoking more than ½ pack per day) or having quit smoking (½ pack per day) for less than 3 months.
  • Active, chronic, or recurrent infection.
  • Compromised immune system (e.g. diabetes).
  • Hypersensitivity to analgesic agents.
  • Co-morbid condition that could limit ability to participate in the study or to comply with follow-up requirements.
  • Pregnant or breastfeeding.
  • Any issue that, at the discretion of the investigator, would contra-indicate the subject's participation.

Outcomes

Primary Outcomes

Assess level of aesthetic improvement using ASAS scale 6 months post last treatment

Time Frame: 6 months post last treatment

Assessing the improvement in the aesthetic appearance of the subject based on the Acne Scar scale comparing baseline to 6 months post last treatment. Grades range 0-4. Clear =0; Very Mild=1; Mild= 2; Moderate= 3; Severe= 4

Assess level of aesthetic improvement using POSAS scale 6 months post last treatment

Time Frame: 6 months post last treatment

Assessing the improvement in the aesthetic appearance of the subject based on the POSAS scale comparing baseline to 6 months post last treatment. Parameters of vascularity, pigmentation, thickness, relief, and pliability, range from 1 to 10. normal skin =1; worst scar imaginable =10.

Secondary Outcomes

  • Assess safety profile by recording all adverse events reported during study(6 months post last treatment)

Study Sites (1)

Loading locations...

Similar Trials